The Covishield vaccine made by Serum Institute of India, which has partnered with British pharmaceutical firm AstraZeneca; and
Covaxin, being developed by Bharat Biotech in collaboration with the Indian Council of Medical Analysis (ICMR) have already utilized for authorisation.